ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,522.40
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,816.83
      -0.14%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Schrodinger Inc (SDGR) Quote

      Schrodinger Inc

      Schrodinger Inc (SDGR)

      NASDAQ
      22.42
      0.13
      (0.58%)
      Closed July 26 4:00PM
      Delayed by 15 minutes
      22.22
      -0.20
      (-0.89%)
      After Hours: 6:56PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      22.22
      Bid
      22.21
      Ask
      22.80
      Volume
      449,951
      22.06 Day's Range 22.96
      18.21 52 Week Range 52.81
      Market Cap
      1.615B
      Previous Close
      22.29
      Open
      22.81
      Last Trade
      465
      @
      22.22
      (formt)
      Last Trade Time
      Financial Volume
      $ 10,070,738
      VWAP
      22.3819
      Average Volume (3m)
      680,698
      Shares Outstanding
      72,679,390
      Dividend Yield
      -
      PE Ratio
      40.05
      Earnings Per Share (EPS)
      0.56
      Revenue
      216.67M
      Net Profit
      40.72M

      About Schrodinger Inc

      Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the... Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. Schrodinger generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.schrodinger.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Schrodinger Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SDGR. The last closing price for Schrodinger was $22.29. Over the last year, Schrodinger shares have traded in a share price range of $ 18.21 to $ 52.81.

      Schrodinger currently has 72,679,390 shares outstanding. The market capitalization of Schrodinger is $1.62 billion. Schrodinger has a price to earnings ratio (PE ratio) of 40.05.

      Schrodinger (SDGR) Options Flow Summary

      SDGR Options Flow

      Overall Flow

      Bearish

      Net Premium

      -71k

      Calls / Puts

      0.00%

      Buys / Sells

      100.00%

      OTM / ITM

      0.00%

      Sweeps Ratio

      0.00%

      SDGR Latest News

      More News

      Schrödinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive Toxicology

      Initiative initially funded by $10 million grant from the Bill & Melinda Gates Foundation Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way...

      16 hours ago
      Business Wire

      Schrödinger to Announce Second Quarter 2024 Financial Results on July 31

      Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its second quarter 2024 financial results on...

      July 17 2024
      Business Wire

      Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

      Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on July 12, 2024, the company...

      July 16 2024
      Business Wire

      Form 8-K - Current report

      June 18 2024
      Edgar (US Regulatory)

      Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

      Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on June 11, 2024, the company...

      June 14 2024
      Business Wire

      Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

      May 30 2024
      Edgar (US Regulatory)

      Schrödinger to Present at Jefferies Global Healthcare Conference

      Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in a...

      May 22 2024
      Business Wire

      Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

      Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on May 16, 2024, the company...

      May 17 2024
      Business Wire

      Schrödinger Reports First Quarter 2024 Financial Results

      First Quarter Total Revenue of $36.6 Million, Software Revenue of $33.4 Million Announces FDA Clearance of Investigational New Drug Application for SGR-3515, a Novel Wee1/Myt1 Inhibitor SGR-1505...

      May 01 2024
      Business Wire

      Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

      Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on April 15, 2024, the company...

      April 18 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.341.5539305301621.8823.2421.1669763422.36238177CS
      42.9315.18921721119.2924.5718.7465952621.72990871CS
      12-1.5-6.3237774030423.7225.1918.2168069821.6767029CS
      26-5.46-19.72543352627.6833.6318.2179215624.80303517CS
      52-26.15-54.062435393848.3752.8118.2182411028.74456519CS
      156-46.99-67.894812888369.2171.2215.8578348232.74901777CS
      260-8.23-27.027914614130.4511715.8589230846.00938358CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WINTWindtree Therapeutics Inc
      $ 8.24
      (150.46%)
      		48.57M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NBSTWNewbury Street Acquisition Corporation
      $ 0.1349
      (92.71%)
      		122.1k
      YIBOPlanet Image International Ltd
      $ 2.915
      (53.43%)
      		259.77k
      CREVCarbon Revolution Public Ltd
      $ 9.00
      (45.87%)
      		8.06M
      NMHINatures Miracle Holding Inc
      $ 0.2035
      (-48.06%)
      		7.69M
      TANHTantech Holdings Ltd
      $ 0.2585
      (-47.23%)
      		6.75M
      DXCMDexCom Inc
      $ 64.00
      (-40.66%)
      		53.92M
      PSIGPS International Group Ltd
      $ 1.42
      (-31.40%)
      		716.26k
      POAIPredictive Oncology Inc
      $ 1.36
      (-27.27%)
      		6.02M
      SLNASelina Hospitality PLC
      $ 0.0305
      (-18.88%)
      		408.45M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NVDANVIDIA Corporation
      $ 113.06
      (0.69%)
      		293.33M
      SQQQProShares UltraPro Short QQQ
      $ 9.10
      (-2.88%)
      		176.49M
      SGMOSangamo Therapeutics Inc
      $ 0.8612
      (28.15%)
      		123.71M

      SDGR Discussion

      View Posts
      lambchops lambchops 1 week ago
      Anybody interested on posting on this one?

      LC

      👍️0
      scotsand scotsand 10 months ago
      This needs to turn around soon. So oversold.
      👍️0
      scotsand scotsand 1 year ago
      Beast mode
      👍️0
      scotsand scotsand 1 year ago
      Love this ticker
      👍️0
      scotsand scotsand 1 year ago
      Up 20%. Guess was right… adding.
      👍️0
      scotsand scotsand 2 years ago
      Now is the time to add.
      👍️0
      Porterhouse10 Porterhouse10 3 years ago
      Cathy Woods adding
      👍️0
      nowwhat2 nowwhat2 3 years ago



      👍️0
      adtime adtime 3 years ago
      This was a fun move hope someone followed ;) 8% at peak today ftw
      👍️0
      adtime adtime 3 years ago
      Nice set up if gets into 60
      👍️0
      ernie44 ernie44 3 years ago
      M and A -------------------------
      merger looming---microsoft
      👍️0
      Bucketh3ad Bucketh3ad 4 years ago
      Smh
      👍️0
      chrispy2468 chrispy2468 4 years ago
      Any insight to this upward move after hours?
      👍️0
      canadiansalmongal canadiansalmongal 4 years ago
      Very Solid company with HUGE money supporting it...Long term Hold this is a golden ticket going forward $100 PT this time next year!
      👍️0
      chrispy2468 chrispy2468 4 years ago
      Little action AH
      👍️0
      RodgeDodger RodgeDodger 4 years ago
      Still running
      👍️0
      crudeoil24 crudeoil24 4 years ago
      I am not holding shares. It may run some more, plus not everyone is familiar with Citron the beast! > LOL.
      👍️0
      realfast95 realfast95 4 years ago
      yea he exaggerates his long ideas. TLRY,RVLV come to mind
      👍️0
      crudeoil24 crudeoil24 4 years ago
      Citron > will they be shorting tomorrow? Playing off the TSLA hype!

      👍️0
      chrispy2468 chrispy2468 4 years ago
      Bullish
      👍️0
      TheFinalCD TheFinalCD 4 years ago
      https://citronresearch.com/schrodinger-sdgr-taking-drug-discovery-to-the-space-age/
      👍️0
      realfast95 realfast95 4 years ago
      Citron pump

      https://twitter.com/CitronResearch/status/1230538195726503942

      Citron Research
      @CitronResearch
      $SDGR the most important IPO past 5 years. Taking drug discovery to "space age". The parallels to an early stage $TSLA are too obvious to ignore. Don't take Citron's word, look at the majority shareholders AI molecular simulation is real disruption. TGT- $80

      👍️0
      RodgeDodger RodgeDodger 4 years ago
      Still running
      👍️0
      crudeoil24 crudeoil24 4 years ago
      Schrodinger Shares Surge 55% After IPO Priced Above High End of Range >SDGR
      12:39 pm ET February 6, 2020 (Dow Jones) Print
      By Colin Kellaher

      Shares of Schrodinger Inc. (SDGR) jumped more than 55% in their trading debut Thursday after the drug discovery software company's upsized initial public offering of 11.9 million shares was priced at $17 apiece, above the expected range.

      Schrodinger shares recently were trading at $26.54, up about 56%, after opening at $26.

      The New York company, whose investors include D.E. Shaw and the Bill & Melinda Gates Foundation, previously said it planned to sell 10 million shares at $14 to $16 each in the IPO.

      The company has granted the underwriters an option to buy up to 1.78 million additional shares.
      👍️0
      crudeoil24 crudeoil24 4 years ago
      Schrodinger Inc is headquartered in New York City, New York, United States and is a software publisher. The company's key areas of interest are Computational Chemistry Software, Molecular Modeling, Dockings, Homology Modeling, Cheminformatics, Pharmacophore Modeling, Qsars, Computational Biology, Computer Chemistry, Quantum Chemistry, Software For Chemistry. The company was founded in 1995.

      👍️0

      Your Recent History

      NASDAQ
      SDGR
      Schrodinger
      Delayed Upgrade Clock